Lantern Pharma

Expansion of RADR platform adds new AI capabilities for the automated identification of new and effective combination therapy regimens for…

Lantern Pharma, an artificial intelligence ("AI") company developing targeted and transformative cancer therapies using its proprietary RADR AI and…

Lantern will leverage its proprietary AI platform, RADR, to rapidly develop novel cryptophycin-antibody drug conjugates (ADCs), which represent…

Lantern Pharma, a clinical-stage biopharmaceutical company using its proprietary RADR artificial intelligence ("AI") and machine learning (“ML”)…

Lantern Pharma a clinical-stage biopharmaceutical company using its proprietary RADR artificial intelligence ("AI") and machine learning (“ML”)…

Lantern Pharma a clinical-stage biopharmaceutical company using its proprietary RADR artificial intelligence ("AI") and machine learning (“ML”)…

Lantern Pharma, a clinical-stage biopharmaceutical company using its proprietary RADR artificial intelligence (AI) and machine learning (ML) platform…

Lantern Pharma  a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("AI") and machine learning (“ML”)…

Lantern Pharma, a clinical stage biopharmaceutical company using its proprietary RADR artificial intelligence ("AI") and machine learning (“ML”)…

Lantern Pharma, a clinical stage biopharmaceutical company using its proprietary RADR artificial intelligence ("A.I.") and machine learning (“M.L.”)…